PRI grows by almost 60% in 2017 – Why not the US?0

The PRI membership has grown by approximately 60% in the last financial year. A mixture of pharmaceutical companies, traditional LBP developers and manufacturers, several start-ups (which is great because each one brings different science and innovation), sampling, DNA sequencing, CRO’s, CMOs, consultants, investment funds…the list goes on!

This growth in membership of course is a fair reflection of the buzz being felt in the Human Microbiome space and justifies our decision to focus on Microbiotic Medicinal Products (in particular LBPs). Another point of focus is of course that we are a European organisation looking to offer a clear regulatory pathway for our members when they take their products to market in Europe. We feel strongly that in order to do this we will also need to attract new members from North America and in the long term Asia.

November will be an interesting month; I’ll be traveling to the US and will be meeting with many people at the following conferences –

I’ll be happy to meet with people interested in the PRI at any of these events or even companies based in San Diego/La Jolla, DC or New York! Email or call on 0033661245717 and we can set up a meeting.

Richard Ellis, Business Development Manager, PRI

Leave a Comment